Ashvattha unit Orpheris enrols first patients in Phase II PRANA trial

PRANA is a double-blind, placebo-controlled Phase II clinical trial that evaluates the efficacy of OP-101 in patients with severe Covid-19. Credit: Ri Butov from Pixabay.



  • CTA